Evrima Technologies

About:

Evrima transforms the recruitment process for clinical trials to help clinicians accelerate timelines and increase patient awareness.

Website: https://evrima.com.au/

Twitter/X: EvrimaClinical

Top Investors: Artesian VC, Wavemaker Partners, BridgeLane Capital

Description:

Evrima Technologies provides clinical trial recruitment solutions to speed up research and bring new treatments to patients in need. Evrima Technologies has a global impact on clinical trial timelines, allowing the industry to advance medical research more quickly, and allowing people to access the therapies they require. Evrima Technologies is on a mission to help advance medical development by accelerating patient identification and recruitment. Evrima Technologies reduces the administrative burden on researchers, allowing them to focus on the high-value clinical work required to get new medicines from bench to bedside.

Total Funding Amount:

3M AUD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Leichhardt, New South Wales, Australia

Founded Date:

2019-01-01

Contact Email:

enquiries(AT)evrima.com.au

Founders:

Charlotte Bradshaw

Number of Employees:

11-50

Last Funding Date:

2022-09-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai